omniture
logo
Search
SNBIOSCIENCE
Media Room

Latest News

rss

SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer

SEOUL, South Korea, May 9, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announ...

2024-05-10 12:00 1458
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer

SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer

SEOUL, South Korea, Feb. 29, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) anno...

2024-02-29 18:09 1615

SN Bioscience Announces Phase 1 Study Results of SNB-101 (SN-38 Nanoparticle Anti-cancer Drug) at ESMO

- Impressive safety and efficacy for solid cancer patients followed by global clinical study plan ...

2023-10-27 13:34 1438
SN Bioscience Announces Phase 1 Study Results of SNB-101 (SN-38 Nanoparticle Anti-cancer Drug) at ESMO

US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer

SEONGNAM, South Korea, July 20, 2023 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) a...

2023-07-21 08:15 1910

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

* First Generic of Abraxane in Korea, World 4th Commercial Scale-Up * Global tech-transfer expec...

2023-01-26 14:31 2070